Next Article in Journal
Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAFV600E-Specific Inhibitor)
Next Article in Special Issue
Emerging and Established Models of Bone Metastasis
Previous Article in Journal
Targeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies
Previous Article in Special Issue
Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases
 
 
Review

Article Versions Notes

Cancers 2018, 10(6), 156; https://doi.org/10.3390/cancers10060156
Action Date Notes Link
article xml file uploaded 24 May 2018 13:10 CEST Original file -
article xml uploaded. 24 May 2018 13:10 CEST Update https://www.mdpi.com/2072-6694/10/6/156/xml
article pdf uploaded. 24 May 2018 13:10 CEST Version of Record https://www.mdpi.com/2072-6694/10/6/156/pdf
article html file updated 24 May 2018 13:12 CEST Original file -
article html file updated 25 June 2018 11:48 CEST Update -
article html file updated 30 March 2019 04:17 CET Update -
article html file updated 16 April 2019 17:25 CEST Update -
article html file updated 30 April 2019 16:58 CEST Update -
article html file updated 9 February 2020 18:54 CET Update https://www.mdpi.com/2072-6694/10/6/156/html
Back to TopTop